Skip to main content
. 2020 Oct 14;46:101102. doi: 10.1016/j.molmet.2020.101102

Figure 1.

Figure 1

Arrows indicate the time from injection (or oral administration in the case of oral semaglutide) to peak plasma concentrations (Cmax) for GLP-1 RAs (Tmax). For references, please see [20]. Peak plasma concentrations may determine the time when nausea and vomiting are observed with GLP-1 RA treatment. The extremely slow absorption of once-weekly exenatide does not allow identification of a peak.